JAMA Psychiatry
Sonja LaBianca, Mette Lise Lousdal, Morten Dybdahl Krebs, Ole Sahlholdt Hansen, Kajsa-Lotta Georgii Hellberg, Mischa Lundberg, Johanne Østerby Sørensen, Jesper R. Gådin, Henrik Ohlsson, Jakob Grove, Anders Børglum, Esben Agerbo, Thomas Werge, Clara Albiñana, Bjarni J. Vilhjálmsson, Kenneth S. Kendler, Oleguer Plana-Ripoll, Andrew J. Schork, iPSYCH Study Consortium and Autism Spectrum Disorder Working Group of the Psychiatric Genomics Consortium, Merete Nordentoft, Ole Mors Mors, Preben Bo Mortensen, Ditte Demontis, Anna Starnawska, Thomas Damm Als, Alfonso Buil, Anders Rosengren, Andres Ingasson, Dorte Helenius, Richard Zetterberg, Carsten Bøcker Pedersen, Jakob Christensen, Liselotte Pedersen, Marianne Giørtz Pedersen, Jonas Bybjerg-Grauholm, Marie Bækvad-Hansen, Alexandra Havdahl, Angel Carracedo, Elemi J. Breetvelt, Elizabeth C. Corfield
Importance The incidences of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) have increased markedly over recent decades, raising concerns about the emergence of new risk factors. Current literature typically attributes increased rates to changes in diagnostic practice, stigmatization, and awareness, but critically few studies have explored changes in underlying risk factors. Objective To assess changes in the genetic risk profile of individuals diagnosed with ASD or ADHD by year …
1 Zitationen